# Gene Therapy Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Biotechnology](https://www.ihealthcareanalyst.com/reports/biotechnology/amp/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Gene Therapy Market by Indication (Acute Lymphocytic Leukemia, Inherited Retinal Disease, Diffuse Large B-cell Lymphoma, Adenosine Deaminase Severe Combined Immunodeficiency Disease, Melanoma, Sickle Cell Beta Thalassemia Disease, Head and Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy, Others), Vector Type (Lentivirus, Adeno-Associated Virus, Retrovirus, Modified Herpes Simplex Virus, Adenovirus, Non-Viral Plasmid Vector, Others) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Gene therapy has three facets namely, gene silencing using siRNA, shRNA and miRNA, gene replacement where the desired gene in the form of plasmids and viral vectors, are directly administered and finally gene editing based therapy where mutations are modified using specific nucleases such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short tandem repeats (CRISPR)/CRISPR-associated protein (Cas)-associated nucleases.

The global gene therapy market research report provides market size ($million 2023 to 2033), market share analysis, growth trends and forecast (CAGR%, 2025 to 2033).

The global gene therapy market segmented by indication (acute lymphocytic leukemia, inherited retinal disease, diffuse large b-cell lymphoma, adenosine deaminase severe combined immunodeficiency disease, melanoma, sickle cell beta thalassemia disease, head and neck squamous cell carcinoma, peripheral arterial disease, spinal muscular atrophy, others), vector type (lentivirus, adeno-associated virus, retrovirus, modified herpes simplex virus, adenovirus, non-viral plasmid vector, others), and geography.

The global gene therapy market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

In addition, the global gene therapy market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global gene therapy market and profiled in this report include American Gene Technologies International, Inc., Applied Genetic Technologies Corporation, Astellas Pharma, Inc., Benitec Biopharma Ltd., BioMarin Pharmaceuticals, Inc., Bluebird Bio, Inc., Bristol-Myers Squibb Company, Calimmune, Inc., Cellectis S.A., Dimension Therapeutics, Inc., Epeius Biotechnologies Corporation, Gene Biotherapeutics, Inc. (Taxus Cardium Pharmaceuticals Group), Gensight Biologics S.A., Gilead Lifesciences, Inc., Novartis AG, Orchard Therapeutics plc, Oxford BioMedica plc, REGENXBIO, Inc., Roche Holding AG, Sanofi S.A., Sangamo Therapeutics, Inc., Shanghai Sunway Biotech Co., Ltd., Sibiono GeneTech Co., Ltd., Takeda Pharmaceutical Company (Shire plc), Transgene S.A., and UniQure N.V.

**DATA INCLUDED:** Gene Therapy Market Size, Gene Therapy Market Share, Gene Therapy Market Growth Rates, Gene Therapy Market Trends, and Gene Therapy Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Gene Therapy Market by Indication (Acute Lymphocytic Leukemia, Inherited Retinal Disease, Diffuse Large B-cell Lymphoma, Adenosine Deaminase Severe Combined Immunodeficiency Disease, Melanoma, Sickle Cell Beta Thalassemia Disease, Head and Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy, Others), Vector Type (Lentivirus, Adeno-Associated Virus, Retrovirus, Modified Herpes Simplex Virus, Adenovirus, Non-Viral Plasmid Vector, Others) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents BT](#tab-table-of-contents-bt)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-discount)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer_ _Market Segments and Companies Tab_\]
    *   Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    *   Source Type
    *   Reagents and Consumables Type
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Company Profiles** \[_refer_ _Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
8.  **Recommendations**
9.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Gene Therapy Market**

1\. **Indication**  
1.1. Acute Lymphocytic Leukemia (ALL)  
1.2. Inherited Retinal Disease (IRD)  
1.3. Diffuse Large B-cell Lymphoma (DLBCL)  
1.4. Adenosine Deaminase (ADA) Severe Combined Immunodeficiency Disease (SCID)  
1.5. Melanoma  
1.6. Sickle Cell Beta Thalassemia Disease  
1.7. Head and Neck Squamous Cell Carcinoma (HNSCC)  
1.8. Peripheral Arterial Disease (PAD)  
1.9. Spinal Muscular Atrophy (SMA)  
1.10. Others

2\. **Vector Type**  
2.1. Lentivirus  
2.2. Adeno-Associated Virus (AAV)  
2.3. Retrovirus  
2.4. Modified Herpes Simplex Virus  
2.5. Adenovirus  
2.6. Non-Viral Plasmid Vector  
2.7. Others

3\. **Geography**  
3.1. North America (U.S., Canada)  
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
3.3. Asia Pacific (Japan, China, India, Rest of APAC)  
3.4. Latin America (Brazil, Mexico, Rest of LA)  
3.5. Rest of the World

4\. **Company Profiles**  
4.1. American Gene Technologies International, Inc.  
4.2. Applied Genetic Technologies Corporation  
4.3. Astellas Pharma, Inc.  
4.4. Benitec Biopharma Ltd.  
4.5. BioMarin Pharmaceuticals, Inc.  
4.6. Bluebird Bio, Inc.  
4.7. Bristol-Myers Squibb Company  
4.8. Calimmune, Inc.  
4.9. Cellectis S.A.  
4.10. Dimension Therapeutics, Inc.  
4.11. Epeius Biotechnologies Corporation  
4.12. Gene Biotherapeutics, Inc. (Taxus Cardium Pharmaceuticals Group)  
4.13. Gensight Biologics S.A.  
4.14. Gilead Lifesciences, Inc.  
4.15. Novartis AG  
4.16. Orchard Therapeutics plc  
4.17. Oxford BioMedica plc  
4.18. REGENXBIO, Inc.  
4.19. Roche Holding AG  
4.20. Sanofi S.A.  
4.21. Sangamo Therapeutics, Inc.  
4.22. Shanghai Sunway Biotech Co., Ltd.  
4.23. Sibiono GeneTech Co., Ltd.  
4.24. Takeda Pharmaceutical Company (Shire plc)  
4.25. Transgene S.A.  
4.26. UniQure N.V. 

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#4c3f2d20293f0c2524292d2038242f2d3e292d222d20353f38622f2321)

[](# "Scroll back to top")

Search for: